Renal denervation for hypertension treatment: What have we learnt recently?
Summary
With the results from 3 recent randomised trials and with 2 technologies, Michel Azizi (France) asks Felix Mahfoud (Germany) about the return of renal denervation not only as a treatment of resistant hypertension but also its use in non-end-stage disease and its application in other fields. The results from longer-term real-world registries are showing a continuous fall in blood pressure while not showing an increase in safety events. Will renal denervation most benefit a younger population, and is hypertension the only indication for this treatment? Join us and learn more here…
The content of this video was filmed at EuroPCR 2019: see more videos here…